Fanikos John, Stapinski Carl, Koo Sophia, Kucher Nils, Tsilimingras Kanella, Goldhaber Samuel Z
Department of Pharmacy, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02215, USA.
Am J Cardiol. 2004 Aug 15;94(4):532-5. doi: 10.1016/j.amjcard.2004.04.075.
Anticoagulation in hospitalized patients is frequently associated with medication errors. To determine the extent and severity of this problem, we reviewed consecutively reported, anticoagulation-related medication errors over a 3-year period. We identified 130 medication errors. There were 1.67 medication errors for every 1,000 patients treated with anticoagulants. These were most often associated with unfractionated heparin (66.2%), followed by warfarin (21.5%), low-molecular-weight heparin (9.2%), argatroban (1.5%), and lepirudin (1.5%). There were no deaths attributed to any anticoagulant medication errors, but 6.2% of patients required medical intervention and 1.5% needed prolonged hospitalization. Medication errors frequently occur with anticoagulant therapy in hospitalized patients.
住院患者的抗凝治疗常常与用药错误相关。为了确定这一问题的严重程度,我们回顾了连续三年报告的与抗凝治疗相关的用药错误。我们共识别出130例用药错误。每1000例接受抗凝治疗的患者中出现1.67例用药错误。这些错误最常与普通肝素(66.2%)有关,其次是华法林(21.5%)、低分子肝素(9.2%)、阿加曲班(1.5%)和比伐卢定(1.5%)。没有任何抗凝用药错误导致死亡,但6.2%的患者需要医疗干预,1.5%的患者需要延长住院时间。住院患者抗凝治疗中经常发生用药错误。